ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Hematology Oncology

Top Hematology Oncology Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS WEINER MD

Hematology Oncology

5,740

$688K

355
276 are 65+

23%
patients receiving schedule two controlled substances

Avg: 13%

23%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 16%

$120
Average prescription price

Avg: $234

ROY HALL M.D.

Hematology Oncology

4,478

$232K

546
473 are 65+

5%
patients receiving schedule two controlled substances

Avg: 13%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 16%

$52
Average prescription price

Avg: $234

KARL GUTER MD

Hematology Oncology

3,057

$568K

217
186 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

19%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$186
Average prescription price

Avg: $234

WILLIAM NICHOLS MD

Hematology Oncology

2,148

$282K

196
168 are 65+

19%
patients receiving schedule two controlled substances

Avg: 13%

21%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 16%

$131
Average prescription price

Avg: $234

GRANT HARRER FACP,CCTI

Hematology Oncology

2,140

$351K

176
144 are 65+

9%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$164
Average prescription price

Avg: $234

BROCK WHITTENBERGER MD

Hematology Oncology

1,822

$819K

258
232 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 16%

$450
Average prescription price

Avg: $234

JAMES HUEFTLE MD

Hematology Oncology

1,687

$217K

144
126 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 16%

$129
Average prescription price

Avg: $234

ROGER SANTALA MD

Hematology Oncology

1,241

$817K

198
169 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

7%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$658
Average prescription price

Avg: $234

ALAN THOMAS MD

Hematology Oncology

1,121

$446K

149
126 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 16%

$398
Average prescription price

Avg: $234

MARTIN LUCAS M.D.

Hematology Oncology

945

$356K

133
115 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

13%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 16%

$377
Average prescription price

Avg: $234

DONALD BERDEAUX MD

Hematology Oncology

938

$359K

83
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

27%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 16%

$383
Average prescription price

Avg: $234

DAVID CHRISTIANSON M.D.

Hematology Oncology

819

$173K

109
96 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

16%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 16%

$211
Average prescription price

Avg: $234

PATRICK COBB M.D.

Hematology Oncology

814

$279K

130
110 are 65+

21%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$342
Average prescription price

Avg: $234

MICHAEL SNYDER MD

Hematology Oncology

798

$460K

130
105 are 65+

10%
patients receiving schedule two controlled substances

Avg: 13%

17%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$576
Average prescription price

Avg: $234

SARAH SCOTT MD

Hematology Oncology

778

$35K

109
85 are 65+

22%
patients receiving schedule two controlled substances

Avg: 13%

16%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 16%

$45
Average prescription price

Avg: $234

ANNIE CASTILLO MD

Hematology Oncology

745

$187K

119
91 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 16%

$252
Average prescription price

Avg: $234

BENJAMIN MARCHELLO M.D.

Hematology Oncology

714

$146K

76
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

18%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 16%

$204
Average prescription price

Avg: $234

TROY FIDDLER M.D.

Hematology Oncology

605

$174K

78
62 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 16%

$288
Average prescription price

Avg: $234

LINDA RIES MD

Hematology Oncology

589

$71.5K

109
94 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 16%

$121
Average prescription price

Avg: $234

JACK HENSOLD MD

Hematology Oncology

546

$285K

81
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 16%

$522
Average prescription price

Avg: $234

PATRICK BEATTY MD

Hematology Oncology

520

$277K

99
80 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

17%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 16%

$533
Average prescription price

Avg: $234

KAREN HUNT MD

Hematology Oncology

491

$130K

75
60 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 16%

$265
Average prescription price

Avg: $234

JOHN WARD MD

Hematology Oncology

364

$385K

76
62 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 16%

$1058
Average prescription price

Avg: $234

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank